MIB Agents OsteoBites and osTEAo

By MIB Agents OsteosarcomaMedicine Health & Fitness

MIB Agents OsteoBites and osTEAo episodes

January 29, 2021 OsteoBites S3 Ep4: Lor Randall, MD, "Sarcomatology: A Trans-Disciplinary Approach"
MIB Agents OsteoBites S3 Ep4: Lor Randall, MD, Sarcomatology: A Trans-Disciplinary Approach
Guest Information:
R. Lor Randall, MD, FACS
Professor & Chair, University of California, Davis
David Linn Endowed Chair in Orthopaedic Surgery.
Dr. Randall’s clinical practice and research focus on musculoskeletal surgical oncology and on building leading-edge, trans-disciplinary teams to combat rare cancers of connective tissue in children and adults. His translational research efforts have been recognized internationally. He is also responsible for the development of the Sarcoma Advanced Research and Clinical (SARC) Fellowship, one of the most sought-after clinical training experiences in the world.
Dr. Randall has authored innumerable peer-reviewed articles, book chapters and abstracts in the field of sarcoma surgery and biology. He has received numerous national and international awards and has helped develop Adolescent and Young Adult Cancer Care Programs at Utah and UC Davis.
He has served as president of the Connective Tissue Oncology Society, Musculoskeletal Tumor Society, the Association of Bone and Joint Surgeons and leads the local control subcommittee of the Bone Committee for the Children’s Oncology Group.
...
Panelists Information:
Amy Woodcheke, BS, MHS, PA-C
Matthew Allen, 2021 MIB Junior Board Member, Gamer Agents Leadership Team
Ryan Kennington, OsteoWarriors & 2020 MIB Junior Board Member
Hosted By Ann Graham, OsteoWarrior & MIB Agents President
...
Next week OsteoBites talks with Robbie Majzner, MD of Stanford University School of Medicine, on Unleashing the Pediatric Immune System Against Sarcoma and other Solid Tumors.
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our
community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
...
Register: https://bit.ly/MIBobites
1 hr
January 21, 2021 OsteoBites S2 Ep3: Pete Anderson, MD, PhD "Understanding Lab, Path and Scan Reports and Other Questions Answered"
MIB Agents OsteoBites S2 Ep3: Pete Anderson, MD, PhD of Cleveland Clinic Understanding Lab, Path and Scan Reports and Other Questions Answered.
Guest Information:
Dr. Pete Anderson is an MIB Agents Board Member and MIB Scientific Advisory Board Member. He is a professor and practices pediatric hematology oncology at Cleveland Clinic. He has also practiced at University of Texas MD Anderson Cancer Center, where he was section chief of non-neural solid tumors, and Mayo Clinic, where he launched the pediatric bone marrow transplant program. He received his Medical degree from Mount Sinai School of Medicine. Residency in both internal medicine and pediatrics at Duke; fellowship in pediatric hematology-oncology at University of Minnesota
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
…
What We Do
PROGRAMS:
✨ End-of-Life MISSIONS
✨ Gamer Agents
✨ Agent Writers
✨ Prayer Agents
✨ Healing Hearts Bereaved Parent Support
✨ Ambassador Agents - Peer Support
EDUCATION for physicians, researchers and families:
✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma
✨ MIB Book: Osteosarcoma: From our Families to Yours
RESEARCH:
✨ Annual MIB FACTOR Research Conference
✨ Funding $100,000 annually for OS research
✨ MIB Testing & Research Directory
✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard
....
Kids are still dying with 40+ year old treatments. Help us MakeItBetter.
🔗 https://www.mibagents.org
59 min
January 14, 2021 OsteoBites S2 Ep2: Alejandro Sweet Cordero, MD "Genome-Informed Targeted Therapies for Osteosarcoma"
MIB Agents OsteoBites S2 Ep2: Alejandro Sweet Cordero, MD on Genome-Informed Targeted Therapies for Osteosarcoma.
Guest Information:
Alejandro Sweet-Cordero, MD is a physician-scientist focused on basic and translational sarcoma biology. His interest is in mechanisms driving osteosarcoma and Ewing sarcoma progression, metastasis and therapy resistance. They use patient-derived xenografts and direct analysis of patient tumors as tools for gene discovery. The Sweet-Cordero Lab has expertise in integrative genomic analysis and extensive experience in generating next-generation sequencing datasets for gene and network discovery using both primary tumors and human and mouse model systems.
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
…
What We Do
PROGRAMS:
✨ End-of-Life MISSIONS
✨ Gamer Agents
✨ Agent Writers
✨ Prayer Agents
✨ Healing Hearts Bereaved Parent Support
✨ Ambassador Agents - Peer Support
EDUCATION for physicians, researchers and families:
✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma
✨ MIB Book: Osteosarcoma: From our Families to Yours
RESEARCH:
✨ Annual MIB FACTOR Research Conference
✨ Funding $100,000 annually for OS research
✨ MIB Testing & Research Directory
✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard
....
Kids are still dying with 40+ year old treatments. Help us MakeItBetter.
🔗 https://www.mibagents.org
59 min
January 08, 2021 OsteoBites S2 Ep1: Erin Murphy, Associate Professor, Radiation Oncology at Cleveland Clinic: Radiosurgery and SBRT for Sarcoma”
MIB Agents OsteoBites S2 Ep1: Erin Murphy, Associate Professor, Radiation Oncology at Cleveland Clinic: Radiosurgery and SBRT for Sarcoma”.
Guest Information:
Erin S. Murphy MD is an Associate Professor in the department of radiation oncology at the Cleveland Clinic. She completed residency at the Cleveland Clinic and a fellowship in pediatric radiation oncology at St. Jude Children’s Research Hospital. She specializes in radiotherapy and radiosurgery for brain tumors and pediatric tumors and has given many presentations and has multiple publications on these topics.
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
...
MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.
What We Do
PROGRAMS:
✨ End-of-Life MISSIONS
✨ Gamer Agents
✨ Agent Writers
✨ Prayer Agents
✨ Healing Hearts Bereaved Parent Support
✨ Ambassador Agents - Peer Support
EDUCATION for physicians, researchers and families:
✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma
✨ MIB Book: Osteosarcoma: From our Families to Yours
RESEARCH:
✨ Annual MIB FACTOR Research Conference
✨ Funding $100,000 annually for OS research
✨ MIB Testing & Research Directory
✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard
....
Kids are still dying with 40+ year old treatments. Help us MakeItBetter.
🔗 https://www.mibagents.org
59 min
November 21, 2020 OsteoBites S1 Ep28: Ryan Roberts, MD, PhD. “Dear Lungs, Stop enabling this cancer: Targeting interactions that facilitate osteosarcoma metastasis.”
MIB Agents OsteoBites S1 Ep28: Ryan Roberts, MD, PhD. “Dear Lungs, Stop enabling this cancer: Targeting interactions that facilitate osteosarcoma metastasis.”
Guest Information:
Ryan D. Roberts, MD, PhD
Division of Hematology and Oncology-Nationwide Children’s Hospital
Center for Childhood Cancer and Blood Diseases-Wexner Research Institute at Nationwide Children’s
Translational Therapeutics Program-The James Comprehensive Cancer Center, Ohio State University.
...
His research seeks to understand the mechanisms that support lung metastasis development in osteosarcoma. We focus on the interactions between tumor cells and lung cells, between tumor cells and immune cells, and between individual tumor cells that exhibit distinct types of behavior. By manipulating these interactions using well-tolerated agents, we hope to make the tumor cells much less comfortable in the lung—preventing metastases from forming and rendering resistant tumors treatable.
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
...
Register: https://bit.ly/MIBobites
1 hr
November 15, 2020 OsteoBites S1 Ep27: Brian Crompton, MD, “New Genomic Approaches to Understanding Osteosarcoma”
OsteoBites S1 Ep27: Brian Crompton, MD, “New Genomic Approaches to Understanding Osteosarcoma”
...
Brian D. Crompton, MD
Assistant Professor of Pediatrics
Department of Pediatric Oncology
Dana-Farber Cancer Institute
...
Dr. Crompton’s research focuses on utilizing genomic and proteomic technologies to identify and validate new therapeutic targets for pediatric solid tumors and to develop non-invasive biomarkers of treatment response and resistance in these diseases. We have recently developed a new approach to study tumor genomics through liquid biopsy technologies including the profiling of circulating tumor DNA and circulating tumor cells in blood samples of patients with pediatric solid tumors. Dr. Crompton is also engaged in national efforts to study the biology of osteosarcoma through the Children’s Oncology Group studies and through patient-led research initiatives including the Count Me In project.
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer.
More information at www.mibagents.org
...
Register: https://bit.ly/MIBobites
59 min
October 16, 2020 OsteoBites S1 Ep25: Sulagna Banerjee, PhD, “Modeling Osteosarcoma in Mice”
MIB Agents OsteoBites S1 Ep25: Sulagna Banerjee, PhD, “Modeling Osteosarcoma in Mice”
Guest Information:
*Sulagna Banerjee, PhD
Research Scientist, University of Miami Health System
Sulagna Banerjee Laboratory
Associate Professor, University of Miami’s Miller School of Medicine.
...
Hosted By Ann Graham, OsteoWarrior & MIB Agents President
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
...
Next week, OsteoBites welcome Dr. Jin-Ah Kim of Children’s Cancer Therapy Development Institute. Dr. Kim will be speaking about “Reversing Checkpoint Adaptation: Making Osteosarcoma Treatments Work Better.”
...
Register: https://bit.ly/MIBobites
53 min
September 25, 2020OsteoBites S1 Ep24: Andy Woods & Charles Keller, MD: "Legacy Autopsy”
MIB Agents OsteoBites S1 Ep24: Andy Woods & Charles Keller, MD: "Legacy Autopsy”
Guest Information:
*Andy Woods, BS
Senior Research Scientist & Childhood Cancer Dad
Children’s Cancer Therapy Development Institute (cc-TDI)
*Charles Keller, MD
Scientific Director
Children’s Cancer Therapy Development Institute (cc-TDI)
...
Panelists Information:
Shannon McCormick, MIB Ambassador Agent, OsteoWarrior Sibling

Amanda Levine, OsteoWarrior, Patient Advocate

Hosted By Ann Graham, OsteoWarrior & MIB Agents President
...
Next week OsteoBites takes a break.
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
...
Register: https://bit.ly/MIBobites
1 hr
September 21, 2020 Lauren: Osteosarcoma Survivor, Sibling of OsteoAngel and MIB Jr. Board Member
Lauren: Osteosarcoma Survivor, Sibling of OsteoAngel and MIB Jr. Board Member
Each week we feature a survivor of Osteosarcoma on #SurvivorSaturday. This week, we shared a video from our annual MIB FACTOR 2020 Osteosarcoma Conference. Lauren closed out our conference by sharing hers and her family's story of fighting this disease.
Lauren, an MIB Agent Jr Board Member, had us crying, cheering and on our feet clapping at FACTOR 20. Her story of survivorship, loss, gratitude and grace is inspiring and humbling.
...
More Hope: https://bit.ly/MIBhope
...
Video Production: Maggie Scanlon
10 min
September 18, 2020 OsteoBites S1 Ep23: Brian Flesner, DVM, MS, DACVIM: "Adjuvant Chemotherapy for Canine Osteosarcoma ”
MIB Agents OsteoBites S1 Ep23: Brian Flesner, DVM, MS, DACVIM: "Adjuvant Chemotherapy for Canine Osteosarcoma”
...
Guest Information:
*Brian Flesner, DVM, MS, DACVIM
American College of Veterinary Internal Medicine (ACVIM)
Assistant Professor of Oncology
College of Veterinary Medicine at the University of Missouri
...
In addition to studying #osteosarcoma, Dr. Flesner’s research interests include chemotherapy mechanisms of action and toxicity, cancer-induced pain, and novel chemotherapeutic approaches to combat aggressive neoplasms. Extensively involved in the vibrant clinical trials service at the MU Veterinary Health Center. The trials service sees hundreds of patients annually; notably, 70 dogs with osteosarcoma were enrolled in osteosarcoma specific clinical trials in the past four years. Dr. Flesner is currently site principal-investigator for several ongoing osteosarcoma studies, including three near completion National Cancer Institute COTC nationwide trials.
...
Panelists Information:
*Charlotte Murdoff, OsteoWarrior
*Casey Crossan, MIB Agents Development & Operations Chief
*Hosted By Ann Graham, OsteoWarrior & MIB Agents President
...
Next week on OsteoBites our guest will be Charles Keller, MD and Andy Wood of cc-TDI speaking on
"Legacy Autopsy Gifts: The After-LIfe Gift of Tissue".
...
MIB Agents is a leading pediatric #osteosarcoma nonprofit dedicated to Making It Better for our community of patients, caregivers, doctors, and researchers with the goal of less toxic, more effective treatments and a cure for this aggressive bone cancer. More information at www.mibagents.org
...
Register: https://bit.ly/MIBobites
59 min

About MIB Agents OsteoBites and osTEAo

From the publisher's feed

Each week, MIB Agents talks with the leaders and innovators in osteosarcoma surgery, research, treatment and advocacy. Questions are taken during the webinar and are included in each podcast. More…

Share MIB Agents OsteoBites and osTEAo

Sign up to save your podcasts

MIB Agents OsteoBites and osTEAo

MIB Agents OsteoBites and osTEAo episodes

About MIB Agents OsteoBites and osTEAo

More shows like MIB Agents OsteoBites and osTEAo

The Deep C